Last reviewed · How we verify
NCT02976961: ACQUIRE-ICD
A Personalized and Interactive Web-based Health Care Innovation to Advance the Quality of Care
NA trial testing Supportive care in Implantable Defibrillator User in 478 participants. Completed in 8 May 2023.
31 December 2022
Quick facts
| Lead sponsor | Susanne Schmidt Pedersen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 478 |
| Start date | 6 February 2017 |
| Primary completion | 31 December 2022 |
| Estimated completion | 8 May 2023 |
| Sites | 5 locations across Denmark |
Drugs / interventions tested
- Supportive care — full drug profile →
Conditions studied
- Implantable Defibrillator User — all drugs for Implantable Defibrillator User →
- Distress — all drugs for Distress →
Sponsor
Susanne Schmidt Pedersen
Who can join
18 and older, any sex, with Implantable Defibrillator User or Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the clinical efficacy and cost-effectiveness of the ACQUIRE-ICD care innovation as add-on to usual care as compared to usual care alone in patients with an implantable cardioverter defibrillator.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial.
Pedersen SS, Skovbakke SJ, Wiil UK, Schmidt T, et al · · 2018 · cited 14× · PMID 29969990 · DOI 10.1186/s12872-018-0872-7 -
Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial.
Skov O, Johansen JB, Nielsen JC, Larroudé CE, et al · · 2023 · cited 7× · PMID 38055845 · DOI 10.1093/europace/euad253 -
Psychometric Performance of Florida Patient Acceptance Survey in Danish Implantable Cardioverter Defibrillator Patients.
Skov O, Johansen JB, Nielsen JC, Larroudé CE, et al · · 2025 · cited 1× · PMID 40518690 · DOI 10.1111/pace.15224
Verify or expand the search:
- PubMed search for NCT02976961
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Supportive care
Trials testing the same drug.
- NCT07486089 — Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) · Phase 1, PHASE2 · recruiting
- NCT07510802 — Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC · Phase 1, PHASE2 · recruiting
- NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
- NCT06439654 — Atlantic Lipid Lowering Treatment Optimization Program · NA · recruiting
- NCT05649852 — Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy · NA · recruiting
Other recruiting trials for Implantable Defibrillator User
Currently open trials in the same condition.
- NCT03544489 — Effectiveness of Exercise After an ICD · Phase 2, PHASE3 · recruiting
- NCT06937658 — Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices · NA · recruiting
- NCT06388382 — Investigation of the Audible ICD Alert Tone · recruiting
- NCT06037785 — Self-Management Interventions After an ICD Shock · NA · recruiting
- NCT05835791 — END - VT Cohort Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02976961 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Susanne Schmidt Pedersen
- Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02976961.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing